Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 30 September 2017 2018 THB mm % THB mm % THB mm % Sale Revenue Revenue from selling product under Company’s trademark 1
–2021 Balance by Quarter Change Q2–21 Q1–21 Q2–20 Q2–21 VS Q1–21 Q2–21 VS Q2–20 (Million Baht: MB) (MB) % (MB) % Total revenue 2,081.2 1,824.2 1,187.6 257.0 14.1 893.6 75.2 Total operating expenses
The Stock Exchange of Thailand. 4. Details of the Asset Acquired The Sole Area Development Franchise under Trademark “Wuttisak Clinic” in Eastern Region; and in Icon Branches in Bangkok by granting HHC
the date when the transaction disclosed to The Stock Exchange of Thailand. 4. Details of the Asset Acquired The Sole Area Development Franchise under Trademark “Wuttisak Clinic” in Eastern Region; and
fee afterwards." This English version is prepared by Legal Department with the sole purpose of facilitating the comprehension of foreign participants in rules and regulations promulgated under the
-------------------------------------------------------------------- This English version is prepared by Legal Department with the sole purpose of facilitating the comprehension of foreign participants in the SEC’s rules and regulations and shall not in any event be
fee afterwards." This English version is prepared by Legal Department with the sole purpose of facilitating the comprehension of foreign participants in rules and regulations promulgated under the
-------------------------------------------------------------------- This English version is prepared by Legal Department with the sole purpose of facilitating the comprehension of foreign participants in the SEC’s rules and regulations and shall not in any event be
the sole purpose of facilitating the comprehension of foreign participants in the SEC’s rules and regulations and shall not in any event be construed or interpreted as having effect in substitution for
CONSTRUCTION EXECUTIVE SUMMARY EXECUTIVE SUMMARY 2 Q1’19 Q4’19 Q1’20 change change Btmn Btmn Btmn y-on-y q-on-q Sales and service income 10,257 11,258 11,223 9.4% (0.3%) EBITDA* 2,413 2,938 3,278 35.8% 11.6% Net